Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Sarcoma 2Head & Neck 2Gynecologic 2Gastrointestinal 2Breast 2

Conditions

Breast Neoplasms 3Urogenital Neoplasms 2Stomach Neoplasms 2Sarcoma 2Ovarian Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Head and Neck Neoplasms 2Colorectal Neoplasms 2

Interventions

pembrolizumab 6Drug Therapy 3Cyclophosphamide 3spartalizumab 2fludarabine 2Sirolimus 2Riluzole 2Oncolytic Virotherapy 2Ipilimumab 2Blood Specimen Collection 2vofatamab 1tocilizumab 1saracatinib 1poly ICLC 1pertuzumab 1pazopanib 1liposomal doxorubicin 1ixabepilone 1fludarabine phosphate 1enzalutamide 1durvalumab 1cediranib 1brodalumab 1atezolizumab 1aldesleukin 1advexin 1Ultrasonography 1Tissue Banks 1TKM-080301 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liver Neoplasms × Riluzole × Breast × Clear all
NCT07447050 2026-03-03

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

University of California, Irvine

Phase 2 Recruiting
24 enrolled
BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT06580002 2025-06-26

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

University of California, Irvine

Phase 2 Recruiting
51 enrolled
BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡